Has Ryan Mobley, NP received payments from drug or device companies?

Yes. Drug and device makers reported $21,717 in general payments to Ryan Mobley, NP across 898 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Ryan Mobley, NP did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Ryan Mobley, NP come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Ryan Mobley, NP

Nurse Practitioner · Phoenix, AZNPI 1720022767

Payments from drug & device makers

$21,717in general payments, 2019–2025

Across 898 payments — averaging $24.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AstraZeneca$2K
Novartis$1K
Incyte Corporation$1K
Genentech USA, Inc.$1K
Daiichi Sankyo Inc.$1K
Pfizer$1K
plus $14K from 54 others

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AstraZeneca(2 entities)	70	$1,996
Novartis	78	$1,443
Incyte Corporation	34	$1,190
Genentech USA, Inc.	39	$1,104
Daiichi Sankyo Inc.	34	$1,046
Pfizer	56	$1,044
E.r. Squibb & Sons, L.L.C.	43	$952
Johnson & Johnson	44	$892
Merck	36	$880
Seagen Inc.	29	$782
GSK	30	$771
AbbVie	37	$670
Bristol Myers Squibb	37	$592
Sanofi	20	$570
Sobi, Inc	15	$508
Pharmacyclics LLC, An Abbvie Company	10	$496
Amgen	18	$423
Astellas Pharma US Inc	16	$418
Lilly USA, LLC	16	$398
Bayer	17	$349
Eisai Inc.	15	$341
Array Biopharma Inc	19	$329
Takeda Pharmaceuticals U.S.A., Inc.	11	$308
Gilead(2 entities)	15	$308
Tersera Therapeutics LLC	8	$267
Ipsen Biopharmaceuticals, Inc	12	$224
EMD Serono, Inc.	12	$222
Sumitomo Pharma America, Inc.	3	$221
Regeneron Healthcare Solutions, Inc.	7	$214
Blueprint Medicines Corporation	9	$197
Karyopharm Therapeutics Inc.	8	$178
Puma Biotechnology, Inc.	8	$175
ADC Therapeutics America, Inc.	7	$160
Genmab U.S., Inc.	5	$149
Beone Medicines USA, Inc.	4	$136
Rigel Pharmaceuticals, Inc.	5	$126
Jazz Pharmaceuticals Inc.	5	$124
Exelixis Inc.	5	$124
Kyowa Kirin, Inc.	6	$121
Adaptive Biotechnologies Corporation	4	$91
Sun Pharmaceutical Industries Inc.	4	$87
AVEO Pharmaceuticals, Inc.	4	$78
Deciphera Pharmaceuticals Inc.	3	$74
EUSA Pharma (US) LLC	1	$71
Morphosys, US Inc.	4	$69
Stemline Therapeutics Inc.	3	$66
Springworks Therapeutics, Inc.	3	$65
Syndax Pharmaceuticals, Inc.	2	$58
Mirati Therapeutics, Inc.	2	$58
Taiho Oncology, Inc.	3	$55
Coherus Oncology, Inc.	2	$52
Boehringer Ingelheim	2	$51
Beigene USA, Inc.	2	$48
Pharmaessentia USA Corporation	2	$45
G1 Therapeutics, Inc.	2	$44
Clovis Oncology, Inc.	2	$39
Global Blood Therapeutics, Inc.	2	$33
Recordati_rare_diseases_inc.	1	$27
Acrotech Biopharma Inc.	1	$27
Legend Biotech USA Inc.	1	$25

How this compares

$21,717 in reported general payments places this provider in the 95th percentile of 1,719 nurse practitioner providers in Arizona.

See all nurse practitioner providers in Arizona →

Medicare billing

Part B allowed, 2024

$3,798

Medicare patients

Services billed

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other nurse practitioner in Phoenix

Helena In't VeldPhoenix$64K
Dustin NickersonPhoenix$39K
Anita PalandriPhoenix$20K
Kristina WernerPhoenix$19K
Miranda IsomPhoenix$17K
Catherine LynnPhoenix$16K
Edith GazoPhoenix$15K
Dora QuanPhoenix$14K
Rachael BennettPhoenix$14K
Marianne RosatiPhoenix$11K

See the full list for Arizona →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →